MiniMed Group, Inc. filed 3 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-08-05. Between them they name 4 people, with 3 appointments and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Reported
On July 30, 2026, Courtney Nelson Wills, Senior Vice President, General Counsel and Corporate Secretary, notified MiniMed Group, Inc. ("MiniMed") of her decision to resign from her position, effective September 25, 2026, following an 8-week transition period.
Appointed: David Endicott, Director, effective 2026-06-29
On June 25, 2026, the Board of Directors (the "Board") of MiniMed Group, Inc. ("MiniMed") increased the size of the Board from nine to 11 and appointed David Endicott and Linnea Burman to serve as a directors of the Board to fill the resulting vacancies, effective June 29, 2026.
Appointed: Linnea Burman, Director
Ms. Burman will serve as a class II director whose term expires at the 2027 annual meeting of stockholders.
Departing: Brett Wall, Director, effective 2026-07-03
On May 17, 2026, Brett Wall, a class II director of the Board of Directors (the "Board") of MiniMed Group, Inc. ("MiniMed") and member of the Board's Nominating and Corporate Governance Committee, notified the Board that he will resign from the Board effective July 3, 2026.
Appointed: Scott Cundy, Director, effective 2026-07-03
On May 18, 2026, Scott Cundy was appointed to serve as a director of the Board, effective July 3, 2026, to fill the vacancy resulting from Mr. Wall's departure.
Find people with the same kind of experience as the Director at MiniMed Group, Inc., with the record behind each one.
Find candidates like Director at MiniMed Group, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time MiniMed Group, Inc. is in the news or changes leadership.
Get an alert when MiniMed Group, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for MiniMed Group, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.